Intellectual Property India Publishes Patent Application for 'Benzimidazole And Aza-Benzimidazole Based Il-17a Modulators And Uses Thereof' Filed by Dice Alpha, Inc.

MUMBAI, India, Sept. 12 -- Intellectual Property India has published a patent application (202517080622 A) filed by Dice Alpha, Inc., Indianapolis, on Aug. 26, for 'benzimidazole and aza-benzimidazole based il-17a modulators and uses thereof.'

Inventor(s) include Reilly, Maureen Kay; Fatheree, Paul R.; Freidberg, Michael D.; Belabed, Hassane; and Brandt, Gary Edward Lee.

The application for the patent was published on Sept. 12, under issue no. 37/2025.

According to the abstract released by the Intellectual Property India: "The disclosure herein provides benzimidazole and aza-benzimidazole based compounds of Formula (I) and pharmaceutical compositions thereof, for the modulation of IL-17A, useful in the treatment of inflammatory conditions such as psoriasis."

The patent application was internationally filed on Jan. 29, 2024, under International application No.PCT/US2024/013391.

Disclaimer: Curated by HT Syndication.